The ratio of glycated albumin to hemoglobin A1c measured in IFCC units accurately represents the glycation gap-Reference-Cited by-同舟云学术

The ratio of glycated albumin to hemoglobin A1c measured in IFCC units accurately represents the glycation gap

Published:2015 Issue:2 Volume:62 Page:161-172
ISSN:0918-8959
Container-title:Endocrine Journal
language:en
Short-container-title:Endocr J

Author:

Akatsuka Junya¹,Mochizuki Mie²,Musha Ikuma¹,Ohtake Akira¹,Kobayashi Kisho²,Kikuchi Toru³,Kikuchi Nobuyuki⁴,Kawamura Tomoyuki⁵,Urakami Tatsuhiko⁶,Sugihara Shigetaka⁷,Hoshino Tadao⁸,Amemiya Shin¹

Affiliation:

1. Department of Pediatrics, Saitama Medial University, Saitama 350-0495, Japan

2. Department of Pediatrics, University of Yamanashi, Yamanashi 409-3898, Japan

3. Division of Pediatrics, Department of Homeostatic Regulation and Development, Niigata University Graduate School of Medical and Dental Sciences, Niigata 950-2181, Japan

4. Department of Pediatrics, Yokohama City University Medical Center, Kanagawa 232-0024, Japan

5. Department of Pediatrics, Osaka City University Graduate School of Medicine, Osaka 545-8585, Japan

6. Department of Pediatrics and Child Health, Nihon University School of Medicine, Tokyo 173-8610, Japan

7. Department of Pediatrics, Tokyo Women’s Medical University Medical Center East, Tokyo 119-8567, Japan

8. Institute of Biopathological Medicine, Kanagawa 243-0813, Japan

Publisher

Japan Endocrine Society

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism

Reference43 articles.

1. 1. Diabetes Control and Complications Trial Research Group (1993) The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Eng J Med 329: 977-986.

2. 2. White NH, Cleary PA, Dahms W, Goldstein D, Malone J, et al. (2001) Beneficial effects of intensive therapy of diabetes during adolescence: outcomes after the conclusion of the Diabetes Control and Complications Trial (DCCT). J Pediatr 139: 804-812.

3. 3. McCarter RJ, Hempe JM, Gomez R, Chalew SA (2004) Biological variation in HbA1c predicts risk of retinopathy and nephropathy in type 1 diabetes. Diabetes Care 27: 1259-1264.

4. 4. Chalew SA, McCarter RJ, Hempe JM (2013) Biological Variation and Hemoglobin A1c: Relevance to Diabetes Management and Complications. Pediatr Diabetes 14: 391-398.

5. 5. Cohen RM, Holmes YR, Chenier TC, Joiner CH (2003) Discordance between HbA1c and fructosamine: evidence for a glycosylation gap and its relation to diabetic nephropathy. Diabetes Care 26: 163-167.

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association of glycation gap with all‐cause and cardiovascular mortality in US adults: A nationwide cohort study;Diabetes, Obesity and Metabolism;2023-04-19

2. Glycaemic patterns in healthy elderly individuals and in those with impaired glucose metabolism – exploring the relationship with nonglycaemic variables;Swiss Medical Weekly;2019-12-17

3. Potential Clinical Error Arising From Use of HbA1c in Diabetes: Effects of the Glycation Gap;Endocrine Reviews;2019-05-10

4. Estimation of glycaemic control in the past month using ratio of glycated albumin to HbA1c;Diabetic Medicine;2018-05-02

5. Glycation gap: An additional tool for glycometabolic monitoring;Clinica Chimica Acta;2016-12